Silo Pharma Income Statement (2019-2025) | SILO

Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) -454.00-316.00268.000.04M294.000.00M0.02M0.02M0.05M0.07M-483.00-164.000.09M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M
Gross Profit (Quarter) 186.000.01M210.00883.00-0.01M-0.12M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M-0.00M-0.00M
Operating items
Research & Development (Quarter) 0.04M0.00M0.02M-0.03M0.05M0.10M0.07M-0.18M0.17M0.00M0.38M-0.65M0.20M0.13M0.17M0.34M0.32M0.39M0.52M1.08M0.59M0.72M0.54M0.31M
Wages, Salaries and Other (Quarter) 0.13M0.08M0.11M0.12M0.08M0.31M0.42M0.42M0.67M0.27M0.33M0.32M0.20M0.25M0.40M0.65M0.37M0.57M0.34M0.45M0.32M0.39M0.26M0.30M0.27M0.30M0.31M0.17M
Selling, General & Administrative (Quarter) 0.01M0.02M0.04M0.01M0.02M0.03M0.01M0.02M0.07M0.05M0.02M0.02M0.04M0.03M0.06M0.10M0.06M0.24M0.06M0.05M
Other Operating Expenses (Quarter) 0.16M0.17M0.20M0.33M0.11M0.97M0.53M0.60M0.80M0.31M0.39M1.11M0.34M0.48M0.53M2.22M0.55M0.76M0.62M0.84M0.51M0.58M0.51M0.75M0.52M0.55M0.61M0.48M
Operating Expenses (Quarter) 0.17M0.19M0.24M0.34M0.16M1.00M0.56M0.59M0.92M0.45M0.48M0.96M0.54M0.51M0.97M1.67M0.82M1.13M0.79M1.18M0.90M1.02M1.03M1.83M1.11M1.27M1.15M0.78M
Operating Income (Quarter) -0.17M-0.19M-0.24M-0.32M-0.16M-1.00M-0.56M0.97M-0.90M-0.44M-0.46M-0.94M-0.53M-0.49M-0.95M1.15M-0.80M-1.11M-0.77M-1.16M-0.88M-1.00M-1.01M2.40M-1.09M-1.25M-1.15M2.38M
EBIT (Quarter) -0.17M-0.19M-0.24M-0.32M-0.16M-1.00M-0.56M0.97M-0.90M-0.44M-0.46M-0.94M-0.53M-0.49M-0.95M1.15M-0.80M-1.11M-0.77M-1.16M-0.88M-1.00M-1.01M2.40M-1.09M-1.25M-1.15M2.38M
Non-operating items
Non Operating Investment Income (Quarter) 6.66M0.01M-0.16M-0.10M-0.15M0.15M390.00-0.00M0.00M
Interest & Investment Income (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M377.00981.000.07M0.06M0.11M0.12M0.11M0.09M0.08M0.08M0.08M0.06M0.04M0.04M0.04M
Other Non Operating Income (Quarter) -0.20M0.06M318.000.07M0.02M0.10M84.00-283.00-0.01M-0.00M-0.00M
Non Operating Income (Quarter) 0.05M-0.05M-0.02M-0.06M-0.08M-0.38M0.06M0.06M0.07M0.05M6.96M-0.14M-0.08M283.00-0.03M-0.28M-0.10M0.10M0.11M0.11M0.08M0.07M0.08M0.08M0.06M0.04M0.04M-0.10M
Net income details
EBT (Quarter) -0.17M-0.19M-0.24M-0.38M-0.24M-0.99M-0.56M-0.60M-0.86M-0.39M6.49M-1.06M-0.60M-0.66M-0.98M-1.66M-0.91M-1.01M-0.66M-1.05M-0.80M-0.93M-0.93M-1.73M-1.03M-1.20M-1.11M-0.88M
Tax Provisions (Quarter) 0.02M0.01M0.60M0.91M
Profit After Tax (Quarter) -0.12M-0.24M-0.27M-0.38M-0.24M-1.38M-0.56M-0.60M-0.93M-0.46M6.47M-2.47M-0.60M-0.66M-0.98M-1.66M-0.91M-1.01M-0.66M-1.12M-0.80M-0.93M-0.93M-1.73M-1.03M-1.20M-1.11M-0.88M
Equity Income (Quarter) -0.06M-0.04M-0.07M-0.00M
Income from Non-Controlling Interests (Quarter) 0.98M1.66M0.91M1.01M
Income from Continuing Operations (Quarter) -0.17M-0.19M-0.24M-0.38M-0.24M-0.99M-0.56M-0.60M-0.86M-0.39M6.47M-1.06M-1.21M-0.66M-0.98M-1.66M-1.81M-1.01M-0.66M-1.05M-0.80M-0.93M-0.93M-1.73M-1.03M-1.20M-1.11M-0.88M
Consolidated Net Income (Quarter) -0.17M-0.19M-0.24M-0.38M-0.24M-0.99M-0.08M-0.19M-0.07M-0.07M0.00M0.23M-0.00M-1.81M-1.01M-0.66M-1.05M-0.80M-0.93M-0.93M-1.73M-1.03M-1.20M-1.11M-0.88M
Income towards Parent Company (Quarter) -0.17M-0.19M-0.24M-0.38M-0.24M-0.99M-0.08M-0.19M-0.07M-0.07M0.00M0.23M-0.00M-1.81M-1.01M-0.66M-1.05M-0.80M-0.93M-0.93M-1.73M-1.03M-1.20M-1.11M-0.88M
Preferred Dividend Payments (Quarter) 0.07M1.40M
Net Income towards Common Stockholders (Quarter) -0.17M-0.24M-0.27M-0.38M-0.24M-1.44M-0.63M-0.79M-2.33M-0.46M6.39M-1.09M-0.60M-0.66M-0.98M-1.66M-1.81M-1.01M-0.66M-1.05M-0.80M-0.93M-0.93M-1.73M-1.03M-1.20M-1.11M-0.88M
Additional items
EPS (Basic) (Quarter) -0.01-0.01-0.01-0.01-0.01-0.04-0.01-0.01-0.03-0.013.24-0.47-0.31-0.33-0.49-0.58-0.29-0.32-0.21-0.36-0.28-0.31-0.22-0.41-0.23-0.19-0.12-0.11
EPS (Weighted Average and Diluted) (Quarter) -0.01-0.01-0.01-0.01-0.01-0.03-0.013.20-0.47-0.31-0.33-0.49-0.58-0.29-0.32-0.21-0.38-0.28-0.31-0.22-0.41-0.23-0.19-0.12-0.11
Shares Outstanding (Weighted Average) (Quarter) 23.42M23.44M23.44M23.47M23.60M46.93M59.51M65.95M85.14M91.03M1.97M1.90M1.97M1.99M1.99M2.28M3.16M3.16M3.11M3.08M2.87M2.96M0.03M3.68M0.03M6.28M0.03M8.38M
Shares Outstanding (Diluted Average) (Quarter) 23.42M23.43M23.47M84.42M65.95M85.14M91.03M1.89M1.92M1.97M1.99M2.00M2.28M3.16M3.16M3.14M3.08M2.87M2.96M4.30M3.68M4.48M5.39M9.33M8.38M
EBITDA (Quarter) -0.17M-0.19M-0.24M-0.32M-0.16M-1.00M-0.56M0.97M-0.90M-0.44M-0.46M-0.94M-0.60M-0.66M-0.98M-1.66M-0.90M-1.02M-0.66M-1.13M-0.77M-0.95M-0.92M-1.75M-1.02M-1.21M-1.11M-0.89M
Interest Expenses (Quarter) 454.00316.00375.000.06M0.08M172.00393.0047.0047.000.00M483.00164.000.00M0.00M0.00M273.000.00M0.00M0.00M274.000.00M0.00M886.000.03M
Shares Outstanding (Quarter) 23.44M23.47M23.49M115.00115.0083.14M85.14M1.70M0.00M1.97M227.00227.0099.40M99.40M100.55M3.16M3.16M0.01M3.11M3.16M3.16M4.08M4.49M4.48M4.48M8.65M10.46M13.32M
Tax Rate (Quarter) 0.29-0.54-100.00-100.00